These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36948401)

  • 1. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
    Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
    Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
    Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
    Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
    J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
    Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
    Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
    Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
    Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
    Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
    J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
    Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
    Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
    Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
    J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
    Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
    Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ; Wu J; Gullapalli RR; Bocklage T
    Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
    Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
    Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
    Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.
    Yoshida A; Makise N; Wakai S; Kawai A; Hiraoka N
    Mod Pathol; 2018 May; 31(5):744-752. PubMed ID: 29327709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
    Stacchiotti S; Pantaleo MA; Astolfi A; Dagrada GP; Negri T; Dei Tos AP; Indio V; Morosi C; Gronchi A; Colombo C; Conca E; Toffolatti L; Tazzari M; Crippa F; Maestro R; Pilotti S; Casali PG
    Eur J Cancer; 2014 Jun; 50(9):1657-64. PubMed ID: 24703573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
    Filion C; Motoi T; Olshen AB; Laé M; Emnett RJ; Gutmann DH; Perry A; Ladanyi M; Labelle Y
    J Pathol; 2009 Jan; 217(1):83-93. PubMed ID: 18855877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.
    Demicco EG; Wang WL; Madewell JE; Huang D; Bui MM; Bridge JA; Meis JM
    Am J Surg Pathol; 2013 May; 37(5):752-62. PubMed ID: 23588370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
    Vergara-Lluri ME; Stohr BA; Puligandla B; Brenholz P; Horvai AE
    Am J Surg Pathol; 2012 Jul; 36(7):1093-8. PubMed ID: 22743288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-articular Extraskeletal EWSR1-Negative NR4A3-Positive Myxoid Chondrosarcoma: A Case Report.
    Lal DN; El-Zammar O; Naous R; Damron TA
    JBJS Case Connect; 2020; 10(2):e0614. PubMed ID: 32649120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.
    Urbini M; Indio V; Astolfi A; Tarantino G; Renne SL; Pilotti S; Dei Tos AP; Maestro R; Collini P; Nannini M; Saponara M; Murrone L; Dagrada GP; Colombo C; Gronchi A; Pession A; Casali PG; Stacchiotti S; Pantaleo MA
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing of extraskeletal myxoid chondrosarcoma.
    Davis EJ; Wu YM; Robinson D; Schuetze SM; Baker LH; Athanikar J; Cao X; Kunju LP; Chinnaiyan AM; Chugh R
    Oncotarget; 2017 Mar; 8(13):21770-21777. PubMed ID: 28423517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.